AHR and neoplasm: Additionally, in vitro experiments demonstrating AhR activation used Kyn concentrations (50–100 μM) exceeding normal physiological plasma Kyn levels [45, 124, 125], suggesting it may be difficult for Kyn to act in vivo; however, the differences between tumor microenvironments and normal plasma composition may make it possible.